My guess is we are getting Breo. If we do, how many months/years do you think the contract would last?
After that call, it seems pretty obvious that either the 100 Breo reps will be the ones to stay on past Advair going generic. Or, they are trying us out to see if we can grow Breo numbers before making a decision
Look at the latest PCBI home screen! BREO & ADVAIR forecasted sales dive around July 1st when Advair generic hits the market. There will be NO NEED for any inventiv/SYNEOS reps after July 1st and that's assuming that generics don't hit until July 1st. My experience has been when a generic is announced the company lays off the sales force the month before the generic is available. That's because almost all the major pharmacy benefit plans will force providers to switch to the generic - HCP's and patients won't have much of a choice.
